• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Study of the incidence of osteoporosis in patients with Sjögren's syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system.

作者信息

Skarlis Charalampos, Palli Eleni, Nezos Andrianos, Koutsilieris Michail, Mavragani Clio P

机构信息

Department of Physiology.

Department of Pathophysiology, School of Medicine, National University of Athens, Athens, Greece.

出版信息

Mediterr J Rheumatol. 2018 Dec 18;29(4):224-227. doi: 10.31138/mjr.29.4.224. eCollection 2018 Dec.

DOI:10.31138/mjr.29.4.224
PMID:32185332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7045933/
Abstract
摘要

相似文献

1
Study of the incidence of osteoporosis in patients with Sjögren's syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system.干燥综合征（pSS）患者骨质疏松症发病率的研究及RANKL/RANK与骨保护素（OPG）系统激活情况的调查。
Mediterr J Rheumatol. 2018 Dec 18;29(4):224-227. doi: 10.31138/mjr.29.4.224. eCollection 2018 Dec.
2
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).骨及其他组织中的核因子κB受体激活剂配体（RANKL）/核因子κB受体激活剂（RANK）/骨保护素系统（综述）
Mol Med Rep. 2015 May;11(5):3212-8. doi: 10.3892/mmr.2015.3152. Epub 2015 Jan 7.
3
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.骨保护素和核因子κB受体活化因子配体在 thalassemia 诱导的骨质疏松症发病机制中的作用：谜题的新线索。
J Bone Miner Res. 2004 May;19(5):722-7. doi: 10.1359/JBMR.040113. Epub 2004 Jan 12.
4
[Electroacupuncture Intervention Improves Cartilage Degeneration and Subchondral Bone Osteoporosis of Knee-joint Possibly by Adjusting OPG/RANK/RANKL Signaling in Ovariectomized Rats].[电针干预可能通过调节去卵巢大鼠的OPG/RANK/RANKL信号通路改善膝关节软骨退变和软骨下骨骨质疏松]
Zhen Ci Yan Jiu. 2018 Dec 25;43(12):781-7. doi: 10.13702/j.1000-0607.170591.
5
Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.骨保护素和核因子κB受体活化因子配体在重型地中海贫血患者骨质疏松发病机制中的作用
Panminerva Med. 2009 Mar;51(1):17-23.
6
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.临床综述#：核因子κB受体激活剂（RANK）/RANK配体/骨保护素的作用：临床意义
J Clin Endocrinol Metab. 2007 Dec;92(12):4514-21. doi: 10.1210/jc.2007-0646. Epub 2007 Sep 25.
7
Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis.COPD 患者骨质疏松症中环流基质金属蛋白酶-9、TNF-α 和 OPG/RANK/RANKL 系统的相互关系。
COPD. 2013 Dec;10(6):650-6. doi: 10.3109/15412555.2013.813928. Epub 2013 Jul 11.
8
Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.1型糖尿病儿童和青少年中较高水平的可溶性核因子κB受体活化因子配体（s-RANKL）和骨保护素可能表明破骨细胞信号增加以及骨量降低的易感性：一项多变量横断面分析。
Osteoporos Int. 2016 Apr;27(4):1631-1643. doi: 10.1007/s00198-015-3422-5. Epub 2015 Nov 20.
9
Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.免疫炎症性心肌病所致心脏重塑中的骨保护素/核因子κB受体活化因子/核因子κB受体活化因子配体轴
Exp Mol Pathol. 2008 Jun;84(3):213-7. doi: 10.1016/j.yexmp.2008.02.004. Epub 2008 Mar 7.
10
Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.核因子-κB 受体激活剂配体和骨保护素在骨细胞生物学中的作用。
J Mol Med (Berl). 2001 Jun;79(5-6):243-53. doi: 10.1007/s001090100226.

引用本文的文献

1
Association between Sjögren syndrome and osteoporosis: A bidirectional Mendelian randomization study.干燥综合征与骨质疏松症之间的关联：一项双向孟德尔随机化研究。
Medicine (Baltimore). 2025 Jul 18;104(29):e43072. doi: 10.1097/MD.0000000000043072.
2
Decreased Risk of Osteoporosis Incident in Subjects Receiving Chinese Herbal Medicine for Treatment: A Retrospective Cohort Study with a Nested Case-Control Analysis.接受中药治疗的受试者骨质疏松症发病风险降低：一项嵌套病例对照分析的回顾性队列研究。
Pharmaceuticals (Basel). 2024 Jun 6;17(6):745. doi: 10.3390/ph17060745.
3
Sjogren's Syndrome: Recent Updates.干燥综合征：最新进展
J Clin Med. 2022 Jan 13;11(2):399. doi: 10.3390/jcm11020399.
4
Musculoskeletal Manifestations in Sjogren's Syndrome: An Orthopedic Point of View.干燥综合征的肌肉骨骼表现：骨科视角
J Clin Med. 2021 Apr 8;10(8):1574. doi: 10.3390/jcm10081574.
5
Mediterranean Journal of Rheumatology December 2018 Highlights.《地中海风湿病学杂志》2018年12月亮点
Mediterr J Rheumatol. 2018 Dec 18;29(4):182-183. doi: 10.31138/mjr.29.4.182. eCollection 2018 Dec.

本文引用的文献

1
Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis.患有和未患有远端肾小管酸中毒的干燥综合征患者的骨矿物质密度
Calcif Tissue Int. 2016 Jun;98(6):573-9. doi: 10.1007/s00223-016-0112-z. Epub 2016 Feb 12.
2
Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.记忆 B 细胞产生 RANKL：类风湿关节炎中 B 细胞与骨侵蚀的联系。
Arthritis Rheumatol. 2016 Apr;68(4):805-16. doi: 10.1002/art.39489.
3
RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.在关节炎症期间，滑膜成纤维细胞表达的 RANKL 主要负责骨质侵蚀。
Ann Rheum Dis. 2016 Jun;75(6):1187-95. doi: 10.1136/annrheumdis-2014-207137. Epub 2015 May 29.
4
Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations.原发性干燥综合征患者的亚临床动脉粥样硬化和骨骼健康受损：患病率、临床及实验室相关性
Arthritis Res Ther. 2015 Apr 11;17(1):99. doi: 10.1186/s13075-015-0613-6.
5
RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.核因子κB受体活化因子配体（RANKL）和骨保护素（OPG）基因多态性：与绝经前系统性红斑狼疮患者椎体骨折及骨密度的相关性
Osteoporos Int. 2015 May;26(5):1563-71. doi: 10.1007/s00198-015-3029-x. Epub 2015 Jan 22.
6
Receptor activating NF-κB ligand (RANKL) is a constitutive intracellular protein in resting human basophils and is strongly induced on their surface by interleukin 3.受体激活核因子κB配体（RANKL）是静息人嗜碱性粒细胞中的一种组成型细胞内蛋白，并在白细胞介素3的作用下在其表面被强烈诱导。
Immunobiology. 2015 May;220(5):692-700. doi: 10.1016/j.imbio.2014.11.009. Epub 2014 Nov 21.
7
Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.免疫、骨骼及其他领域中RANKL-RANK-OPG系统的生物学特性
Front Immunol. 2014 Oct 20;5:511. doi: 10.3389/fimmu.2014.00511. eCollection 2014.
8
Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.骨细胞来源的核因子κB受体活化因子配体（RANKL）是膳食钙缺乏引起骨吸收增加的关键介质。
Bone. 2014 Sep;66:146-54. doi: 10.1016/j.bone.2014.06.006. Epub 2014 Jun 14.
9
Sjögren syndrome.干燥综合征
CMAJ. 2014 Oct 21;186(15):E579-86. doi: 10.1503/cmaj.122037. Epub 2014 Feb 24.
10
Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.绝经前系统性红斑狼疮患者血清护骨素预测亚临床动脉粥样硬化：护骨素与单核细胞趋化蛋白-1的相关性。
Lupus. 2014 Mar;23(3):236-44. doi: 10.1177/0961203313517151.